Form 4 for EOLS Evolus, Inc.
Accepted 2022-09-16 00:00:00 ET · period of report 2022-09-14 · accession 0001387131-22-009830 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-16 | 2022-09-14+ | EOLS | Medytox Inc. | 10% | S - Sale | $10.29 | -97.0K | 7.30M | -1% | -$997.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.00001 par value per share | 2022-09-14 | S | D | 73,000 | $10.27 | 7,328,652 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.10 to $10.54, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnotes (1) and (2) to this Form 4. |
| 2 | Common | Common Stock, $0.00001 par value per share | 2022-09-15 | S | D | 24,000 | $10.34 | 7,304,652 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.17 to $10.43, inclusive. |